Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Annual rare disease conferences, including patient-focused summits, advocacy group meetings, and clinical research symposia, are where new diagnostic tools, gene therapies, and clinical trial results are first shared with families and clinicians. Many of these events offer free or low-cost virtual attendance, recorded sessions, and research updates you can bring directly to your care team. Timing, eligibility, and travel or registration support vary widely by organization and condition, so several important factors deserve a closer look below.
If you are still searching for answers about unexplained or persistent symptoms, understanding your own case is the most useful first step before diving into research updates. A free, instant, online symptom check takes only a few minutes, helps you organize what you are experiencing, and points you toward the right type of specialist and questions to raise at your next appointment.
Last reviewed for medical accuracy: 08/18/2026
Staying connected to the latest research and the Hypophosphatasia (HPP) patient community can make a real difference in understanding your condition, finding support and shaping future treatments. Below you’ll find a guide to annual conferences, virtual events and research‐update resources geared toward HPP patients and families.
Participating in HPP–focused gatherings offers:
Children’s Bone Health Foundation HPP Symposium
American Society for Bone and Mineral Research (ASBMR) Annual Meeting
National Organization for Rare Disorders (NORD) Rare Diseases & Orphan Products Breakthrough Summit
Global Genes RARE Patient Advocacy Summit
International Congress on Rare Diseases & Orphan Drugs (ICORD)
EURORDIS–Rare Diseases Europe Roundtables & Rare Disease Day Events
Not everyone can travel to in‐person meetings. Virtual options include:
HPP Foundation Webinars
Quarterly online sessions covering bone health, dental issues and transition to adult care.
NORD Virtual Summits
Keynote recordings and live Q&A on FDA/EMA updates, trial enrollment and telehealth best practices.
Orphanet Webinars
Free seminars on genetic testing, natural history studies and patient registry development.
RareDiseaseDay.org Digital Program
Live‐streamed panels on mental health, financial planning and community activism for all rare diseases.
Consistent updates help you spot new research and trial openings:
Join Email Lists
• HPP Foundation newsletter
• NORD and Global Genes e-alerts
• ASBMR member announcements
Follow Social Media
• Twitter/X hashtags: #Hypophosphatasia, #RareDiseaseDay
• Facebook groups: HPP patient networks and parent support communities
Monitor ClinicalTrials.gov and EU Clinical Trials Register
Search “hypophosphatasia” to track enrolling studies of enzyme replacement, gene therapy and supportive care.
Read Specialty Journals
• Journal of Bone and Mineral Research
• Orphanet Journal of Rare Diseases
• Genetics in Medicine
Listen to Patient‐Led Podcasts
Firsthand stories often highlight real‐world challenges, treatment side effects and coping strategies.
Preparing in advance ensures you get the most from each event:
Review the Agenda Early
Identify HPP sessions, poster presentations or workshops you can’t miss.
Prepare Questions
List specific inquiries about therapies, trial eligibility or multidisciplinary care teams.
Connect Beforehand
Use event apps or social media to arrange meet-ups with other HPP patients, researchers or advocates.
Budget Strategically
Apply for travel grants or patient scholarships—many organizations reserve funds for rare disease attendees.
Bring Documentation
A summary of your medical history or recent lab results can make one-on-one time with a specialist more productive.
If new symptoms arise or you simply want reassurance between doctor visits, you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a quick way to gather insights before your next appointment.
Attending Hypophosphatasia patient advocacy conferences and engaging with virtual events will keep you at the forefront of research, treatment options and policy efforts. By:
—you can contribute to better care for yourself and others living with HPP.
Finally, always speak to a doctor about any new, serious or life‐threatening symptoms. Your medical team can help interpret the latest research and decide how it applies to your unique health journey.
(References)
* Harari S, Cottin V, Humbert M. Global effort against rare and orphan diseases. Eur Respir Rev. 2012 Sep 1;21(125):171-2. doi: 10.1183/09059180.00004112. PMID: 22941880; PMCID: PMC9487339.
* Harari S, Humbert M, Cottin V. Future perspectives on rare pulmonary diseases and rare presentations of common disorders. Eur Respir Rev. 2013 Sep 1;22(129):199-201. doi: 10.1183/09059180.00004613. PMID: 23997045; PMCID: PMC9487357.
* Arnheiter H, Long G, Aplin A, Harris J, Kelsh R. Triple jeopardy for people with albinism. Pigment Cell Melanoma Res. 2016 Sep;29(5):487. doi: 10.1111/pcmr.12517. PMID: 27615283.
* Blanchard A, Bockenhauer D, Bolignano D, Calò LA, Cosyns E, Devuyst O, Ellison DH, Karet Frankl FE, Knoers NV, Konrad M, Lin SH, Vargas-Poussou R. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 Jan;91(1):24-33. doi: 10.1016/j.kint.2016.09.046. PMID: 28003083.
* Roes K. Editorial on special topic ISCB 2015: "Clinical research design, rare diseases, and personalized medicine". Biom J. 2017 Jul;59(4):607-608. doi: 10.1002/bimj.201700065. PMID: 28677212.
* Elliott PM, Camici P. Transforming care for rare and inherited cardiovascular diseases through education and training. Int J Cardiol. 2018 Apr 15;257:342-343. doi: 10.1016/j.ijcard.2018.01.035. PMID: 29506728.
* Querol L, Crabtree M, Herepath M, Priedane E, Viejo Viejo I, Agush S, Sommerer P. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2021 Oct;268(10):3706-3716. doi: 10.1007/s00415-020-09998-8. Epub 2020 Jun 24. PMID: 32583051; PMCID: PMC8463372.
* Stravitz RT, Fontana RJ, Karvellas C, Durkalski V, McGuire B, Rule JA, Tujios S, Lee WM, Acute Liver Failure Study Group. Future directions in acute liver failure. Hepatology. 2023 Oct 1;78(4):1266-1289. doi: 10.1097/HEP.0000000000000458. Epub 2023 May 16. PMID: 37183883; PMCID: PMC10521792.
* Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group. Consensus on criteria for acromegaly diagnosis and remission. Pituitary. 2024 Feb;27(1):7-22. doi: 10.1007/s11102-023-01360-1. Epub 2023 Nov 3. PMID: 37923946; PMCID: PMC10837217.
* Pfister M, Ratti F, Gores GJ, Lesurtel M, Chiche L, Ebata T, Ardiles V, Valle JW, Heimbach JK, Braconi C, Bruix J, Aldrighetti L, Clavien PA, Consensus4pCCA Collaborative. Recommendations on Perihilar Cholangiocarcinoma. The Milan Jury-Based Consensus. Ann Surg. 2025 Jun 6. doi: 10.1097/SLA.0000000000006773. Epub 2025 Jun 6. PMID: 40478744.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.